Stay updated on Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Sign up to get notified when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.

Latest updates to the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page
- Check4 days agoChange DetectedThe page adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a prominent 'No longer looking for participants' notice to reflect halted recruitment; it also updates the header styling to 'Intervention/Treatment' with a revised version tag to v3.6.0, replacing the previous 'Intervention / Treatment' header and the 'Revision: v3.5.5' entry.SummaryDifference0.3%

- Check12 days agoChange DetectedThe page shows a new revision identifier (v3.5.5) replacing the previous v3.5.4, indicating an behind-the-scenes update to the page's version.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the Study Details page, indicating a content update. This appears to be a minor metadata change with no evident alterations to trial data or eligibility criteria.SummaryDifference0.0%

- Check48 days agoChange DetectedThe Taiwan study site entry is updated from 'Taoyuan, Taiwan, 333' to 'Taoyuan City, Taiwan, 333' to reflect the correct city designation.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page footer has been updated to reflect a new ClinicalTrials.gov release revision (v3.5.3 instead of v3.5.2).SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Satralizumab in Generalized Myasthenia Gravis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.